Emken E A, Adlof R O, Duval S M, Nelson G J
USDA, ARS, NCAUR, Food Quality and Safety Research, Peoria, Illinois 61604, USA.
Lipids. 1998 May;33(5):471-80. doi: 10.1007/s11745-998-0230-x.
The influence of dietary supplementation with 20:4n-6 on uptake and turnover of deuterium-labeled linoleic acid (18:2n-6[d2]) in human plasma lipids and the synthesis of desaturated and elongated n-6 fatty acids from 18:2n-6[d21 were investigated in six adult male subjects. The subjects were fed either a high-arachidonic acid (HIAA) diet containing 1.7 g/d or a low-AA (LOAA) diet containing 0.21 g/d of AA for 50 d. Each subject was then dosed with about 3.5 g of 18:2n-6[d2] as the triglyceride (TG) at 8:00 A.M., 12:00, and 5:00 P.M. The total 18:2n-6[d21] fed to each subject was about 10.4 g and is approximately equal to one-half of the daily intake of 18:2n-6 in a typical U.S. male diet. Nine blood samples were drawn over a 96-h period. Methyl esters of plasma total lipid (TL), TG, phospholipid, and cholesterol ester were analyzed by gas chromatography-mass spectroscopy. Dietary 20:4n-6 supplementation did not affect uptake of 18:2n-6[d2] in plasma lipid classes over the 4-d study period nor the estimated half-life of 24-36 h for 18:2n-6[d2]. The percentages of major deuterium-labeled desaturation and elongation products in plasma TL, as a percentage of total deuterated fatty acids, were 1.35 and 1.34% 18:3n-6[d2]; 0.53 and 0.50% 20:2n-6[d2]; 1.80 and 0.92% 20:3n-6[d2] and 3.13 and 1.51% 20:4n-6[d2] for the LOAA and HIAA diet groups, respectively. Trace amounts (<0.1%) of the 22:4n-6[d2] and 22:5n-6[d2] metabolites were present. Plasma TL concentration data for both 20:3n-6[d2] and 20:4n-6[d2] were 48% lower (P < 0.05) in samples from the HIAA diet group than in samples from the LOAA diet group. For a normal adult male consuming a typical U.S. diet, the estimated accumulation in plasma TL of 20:4n-6 synthesized from 20 g/d (68 mmole) of 18:2n-6 is 677 mg/d (2.13 mmole). Dietary supplementation with 1.5 g/d of 20:4n-6 reduced accumulation of 20:4n-6 synthesized from 20 g/d of 18:2n-6 to about 326 mg/d (1.03 mmole).
在六名成年男性受试者中,研究了膳食补充20:4n-6对人体血浆脂质中氘标记亚油酸(18:2n-6[d2])的摄取和周转以及由18:2n-6[d2]合成去饱和和延长的n-6脂肪酸的影响。受试者分别食用含1.7 g/d花生四烯酸(AA)的高花生四烯酸(HIAA)饮食或含0.21 g/d AA的低AA(LOAA)饮食50天。然后,在上午8:00、中午12:00和下午5:00给每位受试者服用约3.5 g作为甘油三酯(TG)的18:2n-6[d2]。每位受试者摄入的18:2n-6[d2]总量约为10.4 g,大约相当于典型美国男性饮食中18:2n-6每日摄入量的一半。在96小时内采集了九份血样。通过气相色谱-质谱法分析血浆总脂质(TL)、TG、磷脂和胆固醇酯的甲酯。在为期4天的研究期间,膳食补充20:4n-6对血浆脂质类别中18:2n-6[d2]的摄取没有影响,对18:2n-6[d2]的估计半衰期24 - 36小时也没有影响。血浆TL中主要氘标记的去饱和和延长产物占总氘化脂肪酸的百分比,对于LOAA饮食组和HIAA饮食组分别为1.35%和1.34%的18:3n-6[d2];0.53%和0.50%的20:2n-6[d2];1.80%和0.92%的20:3n-6[d2]以及3.13%和1.51%的20:4n-6[d2]。存在痕量(<0.1%)的22:4n-6[d2]和22:5n-6[d2]代谢物。HIAA饮食组样本中20:3n-6[d2]和20:4n-6[d2]的血浆TL浓度数据比LOAA饮食组样本低48%(P < 0.05)。对于食用典型美国饮食的正常成年男性,由20 g/d(68 mmol)的18:2n-6合成的20:4n-6在血浆TL中的估计积累量为677 mg/d(2.13 mmol)。每日补充1.5 g的20:4n-6可将由20 g/d的18:2n-6合成的20:4n-6的积累量降低至约326 mg/d(1.03 mmol)。